Affiliation:
1. Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of
Belgrade, Belgrade, 11000, Serbia
2. Faculty of Medicine, Institute of Pathophysiology "Ljubodrag Buba Mihailović",
University of Belgrade, Belgrade, 11000, Serbia
Abstract
Abstract:
Arterial hypertension (AH) is recognized as the most common illness within
the group of cardiovascular diseases and the most massive chronic non-infectious disease
in the world. The number of hypertensive patients worldwide has reached 1.28 billion,
contributing to an increase in cardiovascular diseases and premature death globally.
The high prevalence of hypertension emphasizes the importance of effectively treating
this condition. Elevated blood pressure often leads to lethal complications (heart failure,
stroke, renal disorders, etc.) if left untreated. Considering an increase in AH prevalence
in the future, a successful therapeutical approach to this disease and its complications is
essential. The goal of AH treatment is to maintain normotensive blood pressure through
various approaches, including lifestyle changes, a well-balanced diet, increased physical
activity, psychoeducation, and, when necessary, pharmacotherapy. The evolving pharmacotherapeutic
landscape reflects the progress made in our understanding of hypertension
and emphasizes the need for continuous innovation to meet the challenges posed by this
prevalent global health concern. The journey toward more effective and tailored treatments
for hypertension is ongoing, and the introduction of new medications plays a pivotal
role in shaping the future of antihypertensive pharmacotherapy.
Funder
Ministry of Science, Technological Development and Innovation of the Republic of Serbia,
Publisher
Bentham Science Publishers Ltd.